Global 3D Bioprinting Equipment Market Professional Survey Report 201 Antidiabetic-SGLT-2-Inhibitor-Market-Report-2017 | Page 4

9 Benelux Antidiabetic SGLT-2 Inhibitor (Volume, Value and Sales Price)
9.1 Benelux Antidiabetic SGLT-2 Inhibitor Sales and Value (2011-2016)
9.1.1 Benelux Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2016)
9.1.2 Benelux Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2016)
9.2 Benelux Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Manufacturers
9.3 Benelux Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type
9.4 Benelux Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Application
10 Europe Antidiabetic SGLT-2 Inhibitor Manufacturers Analysis
10.1 Anderson Hay & Grain Inc.
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.1.2.1 Canagliflozin
10.1.2.2 Empagliflozin
10.1.3 Anderson Hay & Grain Inc. Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross
Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Border Valley
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.2.2.1 Canagliflozin
10.2.2.2 Empagliflozin
10.2.3 Border Valley Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin
(2011-2016)
10.2.4 Main Business/Business Overview
10.3 Sanofi
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.3.2.1 Canagliflozin
10.3.2.2 Empagliflozin
10.3.3 Sanofi Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Johnson & Johnson
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.4.2.1 Canagliflozin
10.4.2.2 Empagliflozin
10.4.3 Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin
(2011-2016)
10.4.4 Main Business/Business Overview
10.5 Bristol-Myers Squibb
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.5.2.1 Canagliflozin
10.5.2.2 Empagliflozin
10.5.3 Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin
(2011-2016)
10.5.4 Main Business/Business Overview
10.6 AstraZeneca